Status:
COMPLETED
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Measles
Mumps
Eligibility:
All Genders
12-18 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the mumps virus strength at the end of shelf-life (expiration date) of an approved vaccine.
Eligibility Criteria
Inclusion
- Healthy children 12 to 18 months of age
Exclusion
- History or prior exposure to measles, mumps, rubella or varicella
- History of anaphylactoid reactions or hypersensitivity to any component of the vaccine, including gelatin and neomycin
Key Trial Info
Start Date :
February 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2001
Estimated Enrollment :
1997 Patients enrolled
Trial Details
Trial ID
NCT00092391
Start Date
February 1 1999
End Date
July 1 2001
Last Update
October 23 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.